[Special Interview] Bayer, strong in CV, female health areas, is trailblazer in cell and gene fields, too

Bayer, long a household word in cardiovascular diseases and women’s health, is distinguishing itself in new blockbuster candidates and novel platforms while adding to its traditional strength.For instance, the global pharmaceutical giant is undergoing crucial changes by replacing its current blockbu